|Association between carotid plaque characteristics and cerebral white matter lesions: one-year follow-up study by MRI.|
|Jump to Full Text|
|PMID: 21347225 Owner: NLM Status: MEDLINE|
|OBJECTIVE: To prospectively assess the relation between carotid plaque characteristics and the development of new cerebral white matter lesions (WMLs) at MRI.
METHODS: Fifty TIA/stroke patients with ipsilateral 30-69% carotid stenosis underwent MRI of the plaque at baseline. Total plaque volume and markers of vulnerability to thromboembolism (lipid-rich necrotic core [LRNC] volume, fibrous cap [FC] status, and presence of intraplaque hemorrhage [IPH]) were assessed. All patients also underwent brain MRI at baseline and after one year. Ipsilateral cerebral WMLs were quantified with a semiautomatic method.
RESULTS: Mean WML volume significantly increased over a one-year period (6.52 vs. 6.97 mm(3), P = 0.005). WML volume at baseline and WML progression did not significantly differ (P>0.05) between patients with 30-49% and patients with 50-69% stenosis. There was a significant correlation between total plaque volume and baseline ipsilateral WML volume (Spearman ρ = 0.393, P = 0.005). There was no significant correlation between total plaque volume and ipsilateral WML progression. There were no significant associations between LRNC volume and WML volume at baseline and WML progression. WML volume at baseline and WML progression did not significantly differ between patients with a thick and intact FC and patients with a thin and/or ruptured FC. WML volume at baseline and WML progression also did not significantly differ between patients with and without IPH.
CONCLUSION: The results of this study indicate that carotid plaque burden is significantly associated with WML severity, but that there is no causal relationship between carotid plaque vulnerability and the occurrence of WMLs.
|Robert M Kwee; Paul A M Hofman; Ed H B M Gronenschild; Robert J van Oostenbrugge; Werner H Mess; Johannes W M ter Berg; Cees L Franke; Arthur G G C Korten; Bé J Meems; Jos M A van Engelshoven; Joachim E Wildberger; M Eline Kooi|
Related Documents :
|3257465 - Decreased t-colony formation by lymphocytes from patients with focal glomerular sclerosis.
10468175 - Giant cell arteritis can be associated with t4-lymphocytic alveolitis.
14601055 - Thymic function and immunoglobulin mutation genotype in b-cell chronic lymphocytic leuk...
3156495 - Erythroderma with spongiotic dermatitis. association with common variable hypogammaglob...
16799245 - Bradycardia-dependent ecg changes in brugada syndrome.
9741545 - Anticardiolipin and anti-beta2-glycoprotein i antibodies in behcet's disease.
|Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2011-02-15|
|Title: PloS one Volume: 6 ISSN: 1932-6203 ISO Abbreviation: PLoS ONE Publication Date: 2011|
|Created Date: 2011-02-24 Completed Date: 2012-04-02 Revised Date: 2013-06-30|
Medline Journal Info:
|Nlm Unique ID: 101285081 Medline TA: PLoS One Country: United States|
|Languages: eng Pagination: e17070 Citation Subset: IM|
|Department of Radiology, Maastricht University Medical Center, Maastricht, The Netherlands. email@example.com|
|APA/MLA Format Download EndNote Download BibTex|
Aged, 80 and over
Brain / pathology*
Carotid Artery Diseases / diagnosis, pathology*
Magnetic Resonance Imaging*
Plaque, Atherosclerotic / diagnosis, pathology*
Journal ID (nlm-ta): PLoS One
Journal ID (publisher-id): plos
Journal ID (pmc): plosone
Publisher: Public Library of Science, San Francisco, USA
Kwee et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received Day: 30 Month: 10 Year: 2010
Accepted Day: 15 Month: 1 Year: 2011
collection publication date: Year: 2011
Electronic publication date: Day: 15 Month: 2 Year: 2011
Volume: 6 Issue: 2
E-location ID: e17070
PubMed Id: 21347225
Publisher Id: PONE-D-10-04481
|Association between Carotid Plaque Characteristics and Cerebral White Matter Lesions: One-Year Follow-Up Study by MRI Alternate Title:Carotid Plaque Vulnerability and WMLs at MRI|
|Robert M. Kwee12*|
|Paul A. M. Hofman1|
|Ed H. B. M. Gronenschild34|
|Robert J. van Oostenbrugge25|
|Werner H. Mess26|
|Johannes W. M. ter. Berg7|
|Cees L. Franke8|
|Arthur G. G. C. Korten9|
|Bé J. Meems10|
|Jos M. A. van Engelshoven12|
|Joachim E. Wildberger12|
|M. Eline Kooi12|
1Department of Radiology, Maastricht University Medical Center, Maastricht, The Netherlands
2Cardiovascular Research Institute Maastricht, Maastricht University Medical Center, Maastricht, The Netherlands
3Department of Psychiatry, Maastricht University Medical Center, Maastricht, The Netherlands
4Department of Neuropsychology, Maastricht University Medical Center, Maastricht, The Netherlands
5Department of Neurology, Maastricht University Medical Center, Maastricht, The Netherlands
6Department of Clinical Neurophysiology, Maastricht University Medical Center, Maastricht, The Netherlands
7Department of Neurology, Orbis Medical Center, Sittard, The Netherlands
8Department of Neurology, Atrium Medical Center, Heerlen, The Netherlands
9Department of Neurology, Laurentius Hospital, Roermond, The Netherlands
10Department of Neurology, Vie Curi Medical Center, Venlo, The Netherlands
|Julius-Maximilians-Universität Würzburg, Germany
|Correspondence: * E-mail: firstname.lastname@example.org
Contributed by footnote: Conceived and designed the experiments: RMK PAMH EHBMG RJvO WHM JWMtB CLF AGGCK BJM JMAvE JEW MEK. Performed the experiments: RMK. Analyzed the data: RMK PAMH EHBMG RJvO WHM JWMtB CLF AGGCK BJM JMAvE JEW MEK. Contributed reagents/materials/analysis tools: EHBMG. Wrote the paper: RMK PAMH EHBMG RJvO WHM JWMtB CLF AGGCK BJM JMAvE JEW MEK.
Carotid atherosclerosis is an important cause of ischemic stroke. The pathogenesis of ischemic stroke due to carotid atherosclerosis can be ascribed to cerebral embolism from carotid plaque and/or hypoperfusion due to stenosis . Large epidemiological studies showed that there also is a relation between the presence and amount of carotid atherosclerosis and white matter lesions (WMLs) , , which are frequently detected by magnetic resonance imaging (MRI) in the aging brain. The presence and severity of WMLs have substantial clinical relevance, because they are associated with cognitive decline , dementia , and impaired mobility . Moreover, it has been shown that WMLs are a strong independent predictor of stroke ,  and global functional decline . It is unclear yet whether the relation between carotid atherosclerosis and WMLs is indirect via shared risk factors or causative in nature. To our knowledge, it has not been investigated yet whether the presence of certain carotid plaque features precedes the development of new WMLs. Therefore, the purpose of the present study was to prospectively assess the relation between carotid plaque characteristics and cerebral WML progression at MRI.
Patients with recent (<3 months) amaurosis fugax, TIA, or minor stroke and an ipsilateral carotid plaque causing 30–69% stenosis, as determined by ultrasonography, were eligible for inclusion. Exclusion criteria were: atrial fibrillation or other cardiogenic cause of TIA/stroke, standard contraindications for MRI, and a renal clearance <30 ml/min/1.73 m2. Participating patients underwent baseline and follow-up MRI after one year (see MRI protocol below). This study was approved by the institutional review board of our hospital. All patients gave written informed consent.
For each patient age and sex were recorded. Hypertension was defined as a systolic blood pressure ≥140 mm Hg and/or a diastolic blood pressure ≥90 mm Hg, or treatment with antihypertensive medication . Diabetes mellitus was defined as reported use of medication for diabetes mellitus or fasting plasma glucose level ≥126 mg/dl . Patients were categorized into current, former and never smokers.
A baseline MRI scan of the carotid plaque ipsilateral to the presumed side of ischemia was obtained using a dedicated 47 mm-diameter surface coil, as described previously . Five MR pulse sequences were acquired: (1) 3D T1-weighted TFE: TR/TI/TE 10.3/900/4.4 ms, flip angle 15°, inversion prepulse, shot interval time 3000 msec, TFE factor 163, slice thickness 3.0 mm; (2) 3D TOF: TR/TE 23/3.9 ms, flip angle 25°, slice thickness 3.0 mm; (3) Multislice T2-weighted TSE: TR/TE 2 heartbeats/50 ms, echo train length 8, slice thickness/gap 2.5/0.5 mm; (4/5) Pre- and post-contrast 2D T1-weighted TSE (double inversion-recovery): TR/TI/TE 1 heartbeat/heart rate dependent/18 ms, echo train length 9, slice thickness/gap 2.5/0.5 mm. The post-contrast T1-weighted TSE sequence was obtained 7-8 minutes after injection of 0.1 mmol/kg body weight of gadopentetate dimeglumine (Magnevist, Bayer Schering Pharma AG, Berlin, Germany). T1 was adjusted according to heart rate and postcontrast T1 relaxation time of blood. For all sequences the FOV was 100×80 mm, with a matrix size of 256×205 (in-plane resolution, 0.39×0.39 mm), except for the T1-weighted TFE sequence (FOV 100×80 mm, matrix size 256×163; in-plane resolution 0.39×0.49 mm).
In addition, brain MRI scans at baseline and after one year follow-up were obtained using a standard quadrature head coil, as described previously . Two MR pulse sequences were acquired: (1) T2-weighted TSE: TR/TE 4820/100 ms, echo train length 12, slice thickness/gap 5.0/0.5 mm; (2) fluid-attenuated inversion recovery (FLAIR): TR/TI/TE 8000/2000/120 ms, echo train length 23, slice thickness/gap 5.0/0.5 mm. For both sequences the FOV was 230×230 mm, with a matrix size of 512×512 mm (in-plane resolution 0.45×0.45 mm).
All MRI examinations were performed on a 1.5-T whole-body scanner (Intera 184.108.40.206, Philips Healthcare, Best, the Netherlands).
MR images of the plaque were evaluated by one investigator (R.M.K.), blinded to all patient information, including brain MR images, using dedicated vessel wall analysis software (VesselMASS, Department of Radiology, Leiden University Medical Center, The Netherlands). For each plaque, total plaque volume, lipid-rich necrotic core (LRNC) volume, fibrous cap (FC) status, and presence of intraplaque hemorrhage (IPH) were assessed (all are histopathologic features of vulnerability to thromboembolism), as described previously ,  (Figure 1 gives an example). Previously, we showed in a comparable group of consecutive patients that intra- and interobserver agreement for assessment of total plaque volume, LRNC volume, and FC status assessment were (very) good (ICC = 0.71–0.92, and κ = 0.60–0.98) , , while intra- and interobserver agreement for the detection of IPH were very good to excellent (κ = 0.86–1.00) .
MR images of the brain (Figure 2 gives an example) were evaluated ≥12 months after carotid plaque analysis by one investigator (R.M.K.) who was blinded to all patient information, the time point at which the MRI examination was performed, and the results of carotid plaque analysis. Three months after the first reading, one observer (R.M.K.) re-evaluated all MR brain images of 20 consecutive patients, blinded to the results of the first reading session, to assess intraobserver variability. In addition, an experienced neuroradiologist (P.A.M.H.) also prospectively analyzed MR brain images of 20 consecutive patients independently to assess interobserver variability. Intra- and interobserver agreement for assessment of WML volume were excellent ICCs of 0.99). Total, deep, and periventricular WML volumes of the ipsilateral cerebral hemisphere were assessed using dedicated semi-automated software (GIANT, E.H.B.M.G., Department of Psychiatry and Neuropsychology, Maastricht University Medical Center, the Netherlands) .
Statistical analysis was performed using SPSS version 11.5 (SPSS Inc, Chicago, USA). Differences between WML volume at baseline and after one-year follow-up were assessed by the Wilcoxon signed-rank test. Associations between clinical parameters and WML volume at baseline and WML volume progression were assessed by Spearman rank correlation tests. Associations between total plaque volume, carotid plaque LRNC volume and ipsilateral WML volume at baseline and WML volume progression were also assessed by Spearman rank correlation tests and a scatter plot was generated. Differences in ipsilateral WML volume at baseline and WML volume progression between patients with different stenosis grade, patients with different FC status, and between those with and without carotid IPH, were evaluated using the Mann-Whitney U test and by generating Box-and-Whisker plots. In addition, an analysis was performed for the relation between carotid plaque characteristics and deep and periventricular WMLs separately, and for the relation between carotid plaque characteristics and for left and right sided plaques separately. Level of significance was set at 0.05.
Fifty Caucasian patients undergoing baseline and follow-up MRI after one year (see MRI protocol below), were included. Patient characteristics are presented in Table 1. Mean time interval between last symptoms and baseline MRI examination was 30±19 days. According to clinical guidelines, all 50 patients were prescribed aspirin and dipyridamole. Forty-seven patients were prescribed statins. No carotid surgical interventions were performed and none of the included patients experienced a stroke during the follow-up period.
Mean ipsilateral WML volume significantly increased over a one-year period (6.52 vs. 6.97 mm3, P = 0.005). Age and hypertension were significantly associated with baseline WML volume, while age and WML volume at baseline were significantly associated with WML progression. In addition, males tended to have higher WML volume at baseline and higher WML progression than woman, albeit these findings were not statistically significant (Table 2).”
Baseline ipsilateral WML volume and WML progression did not significantly differ between 31 patients with 30–49% and 19 patients with 50–69% carotid stenosis (P = 0.689 and P = 0.342, respectively). Total plaque volume and baseline ipsilateral WML volume were significantly correlated (Spearman ρ = 0.393, P = 0.005) (Figure 3A). Total plaque volume and WML progression were not significantly correlated (Spearman ρ = 0.022, P = 0.877) (Figure 3B). In addition, there was no significant association between LRNC volume and baseline ipsilateral WML volume (Spearman ρ = 0.088, P = 0.545) and WML progression (Spearman ρ = 0.053, P = 0.715) (Figure 3C–D). Baseline ipsilateral WML volume and WML progression did not significantly differ between patients with a thick and intact FC and patients with a thin and/or ruptured FC (P = 0.504 and P = 0.867, respectively) (Figure 3E–F). Baseline ipsilateral WML volume and ipsilateral WML progression also did not significantly differ between patients with and without IPH (P = 0.700 and P = 0.917, respectively) (Figure 3G–H). Total plaque volume was significantly associated with ipsilateral periventricular WML volume at baseline (Spearman ρ = 0.426, P = 0.002). There were no significant associations between other carotid plaque characteristics and deep and periventricular WMLs separately. In addition, total plaque volume was (borderline) significantly associated with ipsilateral WML severity at baseline both for left (n = 27) and right (n = 23) sided plaques (Spearman ρ = 0.421, P = 0.029 and Spearman ρ = 0.400, P = 0.058, respectively). There were no significant associations between other carotid plaque characteristics and WMLs at the left and right side separately. Multivariate linear regression analysis, adjusted for age and hypertension, did not show significant relations between carotid plaque features and WML severity and progression.
In the present longitudinal follow-up study, mean ipsilateral WML volume significantly increased in TIA/stroke patients with ipsilateral carotid stenosis over a one-year period.
We found a significant association between carotid plaque burden (measured as total plaque volume) and WML severity. However, we found no associations between MRI features reflecting vulnerability to thromboembolism and ipsilateral WML severity and progression over a one-year period.
Age and hypertension were significantly associated with ipsilateral WML severity at baseline. Age and ipsilateral WML volume at baseline were significantly associated with WML progression. Our findings are consistent with epidemiologic studies which have established that age and hypertension are associated with WML severity and progression , –, and that the amount of WMLs at baseline predicts WML progression , .
We found that carotid stenosis grade is not related to ipsilateral baseline WML volume, which is in line with results of earlier cross-sectional studies investigating the relation between carotid plaque characteristics and WMLs at MRI –.
Plaque burden was found to be associated with WML severity at baseline, which is in accordance to the results of the population-based study by Pico et al. , who assessed carotid plaque burden by ultrasonography.
In the present study, we found no relation between markers of vulnerability to thromboembolism and WML severity and progression. We found no association between ipsilateral LRNC volume and baseline ipsilateral WML volume, which is in accordance to the cross-sectional studies by Patterson et al.  and Ouhlous et al. . We also found no association between the presence of IPH and baseline ipsilateral WML volume, which is in line with Patterson et al. 's findings , but contradicts those of Altaf et al. . Altaf et al.  suggested that embolic events from vulnerable carotid plaques with IPH may contribute to the development of WML. However, the cross-sectional design of their study  precluded the authors from drawing definitive conclusions. In the present longitudinal follow-up study, we found no association between the presence of carotid IPH and progression of ipsilateral WMLs. Finally, we found no associations between LRNC volume and FC status (which are also believed to be markers of plaque vulnerability) and ipsilateral WML progression.
The pathogenesis of WMLs is not fully understood yet. A concurrence of mechanisms (ischemia, blood-brain barrier alterations, edema, loss of autoregulation, etc.) may contribute to the development of WMLs . Brain hypoperfusion due to luminal narrowing by carotid atherosclerosis may be one of the causes of WMLs. The occurrence of WMLs has complex relations with cardiovascular risk factors, and an indirect link between large vessel atherosclerosis and WMLs by shared risk factors is also well possible. The findings of the present study suggest that there is no causal relationship between carotid plaque vulnerability, i.e. thromboembolism from carotid plaques, and the occurrence of WMLs.
Our study has several limitations. First, this was an exploratory study. Although no noticeable effects in the distribution of WML volumes at baseline and WML volume differences after one year for LRNC volume, FC status, and IPH were observed, our findings should be confirmed by an independent study. Second, we only performed MR imaging of plaques ipsilateral to the presumed side of ischemia, which are in general more vulnerable than clinically asymptomatic carotid plaques . Because of time constraints and patient inconvenience, we did not obtain MR images of contralateral asymptomatic plaques. The association between characteristics of clinically asymptomatic plaques and WML progression remains to be investigated. Third, for all patients we assessed WML volumes of the ipsilateral cerebral hemisphere, which may in fact not have been the true internal carotid artery distribution territory for each individual patient. This may only be determined by using dedicated techniques, such as selective arterial spin labeling. Fourth, our follow-up period comprised one year, the period in which carotid plaque vulnerability may be highest after the initial event . Longer follow-up might have detected associations between carotid plaque characteristics and WML progression. However, this may be unlikely because in the present study we also found no association between plaque characteristics and WML severity at baseline. Finally, all patients were prescribed antiplatelet therapy and most patients were prescribed statins for secondary stroke prevention. The use of these medications may have influenced the natural history of carotid plaques, WMLs, and their possible interaction mechanisms. For instance, it has been shown that the use of statins is negatively associated with complicated plaque features , whereas the use of antiplatelet therapy can decrease WML progression . Future studies should ideally be conducted in patients who are not using these medications. However, due to ethical reasons, this can only be done in an asymptomatic population.
In conclusion, in TIA/stroke patients with carotid stenosis, we found an association between carotid plaque burden and WML severity. We found no associations between LRNC volume, FC status, and the presence of IPH ipsilateral WML severity and progression over a one-year period, suggesting that there is no causal relationship between carotid plaque vulnerability and the occurrence of WMLs.
Competing Interests: The authors have declared that no competing interests exist.
Funding: This study was supported by Dutch Heart Foundation grant 2006B061. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
|1.||Moustafa RR,Izquierdo-Garcia D,Jones PS,Graves MJ,Fryer TD,et al. Year: 2010Watershed infarcts in transient ischemic attack/minor stroke with > or = 50% carotid stenosis: hemodynamic or embolic?Stroke411410141620508190|
|2.||de Leeuw FE,de Groot JC,Bots ML,Witteman JC,Oudkerk M,et al. Year: 2000Carotid atherosclerosis and cerebral white matter lesions in a population based magnetic resonance imaging study.J Neurol24729129610836622|
|3.||Pico F,Dufouil C,Lévy C,Besançon V,de Kersaint-Gilly A,et al. Year: 2002Longitudinal study of carotid atherosclerosis and white matter hyperintensities: the EVA-MRI cohort.Cerebrovasc Dis1410911512187015|
|4.||de Leeuw FE,de Groot JC,Achten E,Oudkerk M,Ramos LM,et al. Year: 2001Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study.J Neurol Neurosurg Psychiatry7091411118240|
|5.||de Groot JC,de Leeuw FE,Oudkerk M,Hofman A,Jolles J,et al. Year: 2001Cerebral white matter lesions and subjective cognitive dysfunction: the Rotterdam Scan Study.Neurology561539154511402112|
|6.||Prins ND,van Dijk EJ,den Heijer T,Vermeer SE,Koudstaal PJ,et al. Year: 2004Cerebral white matter lesions and the risk of dementia.Arch Neurol611531153415477506|
|7.||Guttmann CR,Benson R,Warfield SK,Wei X,Anderson MC,et al. Year: 2000White matter abnormalities in mobility-impaired older persons.Neurology541277128310746598|
|8.||Kuller LH,Longstreth WT Jr,Arnold AM,Bernick C,Bryan RN,et al. Year: 2004White matter hyperintensity on cranial magnetic resonance imaging: a predictor of stroke.Cardiovascular Health Study Collaborative Research Group Stroke3518211825|
|9.||Vermeer SE,Hollander M,van Dijk EJ,Hofman A,Koudstaal PJ,et al. Year: 2003Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study.Stroke341126122912690219|
|10.||Inzitari D,Pracucci G,Poggesi A,Carlucci G,Barkhof F. Year: 2009Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort.BMJ339b247719581317|
|11.||Chobanian AV,Bakris GL,Black HR,Cushman WC,Green LA,et al. Year: 2003The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.JAMA2892560257212748199|
|12.||Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. Available: http://www.who.int/diabetes/publications/Definition%20and%20diagnosis%20of%20diabetes_new.pdf. Accessed 2010 Oct 23.|
|13.||Kwee RM,Teule GJ,van Oostenbrugge RJ,Mess WH,Prins MH,et al. Year: 2009Multimodality imaging of carotid artery plaques: 18F-fluoro-2-deoxyglucose positron emission tomography, computed tomography, and magnetic resonance imaging.Stroke403718372419875738|
|14.||Kwee RM,van Engelshoven JM,Mess WH,ter Berg JW,Schreuder FH,et al. Year: 2009Reproducibility of fibrous cap status assessment of carotid artery plaques by contrast-enhanced MRI.Stroke403017302119556528|
|15.||Henskens LH,Kroon AA,van Oostenbrugge RJ,Gronenschild EH,Hofman PA,et al. Year: 2009Associations of ambulatory blood pressure levels with white matter hyperintensity volumes in hypertensive patients.J Hypertens271446145219502993|
|16.||LongstrethJr WT,Manolio TA,Arnold A,Burke GL,Bryan N,et al. Year: 1996Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study.Stroke27127412828711786|
|17.||de Leeuw FE,de Groot JC,Oudkerk M,Witteman JC,Hofman A,et al. Year: 2002Hypertension and cerebral white matter lesions in a prospective cohort study.Brain12576577211912110|
|18.||LongstrethJr WT,Arnold AM,BeauchampJr NJ,Manolio TA,Lefkowitz D,et al. Year: 2005Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study.Stroke36566115569873|
|19.||Gouw AA,van der Flier WM,Fazekas F,van Straaten EC,Pantoni L,et al. Year: 2008Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study.Stroke391414142018323505|
|20.||Schmidt R,Enzinger C,Ropele S,Schmidt H,Fazekas F. Year: 2003Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention Study.Lancet3612046204812814718|
|21.||Altaf N,Morgan PS,Moody A,MacSweeney ST,Gladman JR,et al. Year: 2008Brain white matter hyperintensities are associated with carotid intraplaque hemorrhage.Radiology24820220918566173|
|22.||Patterson AJ,U-King-Im JM,Tang TY,Scoffings DJ,Howarth SP,et al. Year: 2009Association between white matter ischaemia and carotid plaque morphology as defined by high-resolution in vivo MRI.Eur J Vasc Endovasc Surg3814915419447050|
|23.||Ouhlous M,Flach HZ,de Weert TT,Hendriks JM,van Sambeek MR,et al. Year: 2005Carotid plaque composition and cerebral infarction: MR imaging study.AJNR Am J Neuroradiol261044104915891157|
|24.||Pantoni L. Year: 2002Pathophysiology of age-related cerebral white matter changes.Cerebrovasc Dis13'Suppl 271011901236|
|25.||Chaturvedi S,Bruno A,Feasby T,Holloway R,Benavente O,et al. Year: 2005Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Carotid endarterectomy--an evidence-based review: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.Neurology6579480116186516|
|26.||Rothwell PM,Eliasziw M,Gutnikov SA,Fox AJ,Taylor DW,et al. Year: 2003Carotid Endarterectomy Trialists' Collaboration Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis.Lancet36110711612531577|
|27.||Kwee RM,van Oostenbrugge RJ,Prins MH,ter Berg JW,Franke CL,et al. Year: 2010Symptomatic patients with mild and moderate carotid stenosis: plaque features at MRI and association with cardiovascular risk factors and statin use.Stroke411389139320466996|
|28.||Fujita S,Kawaguchi T,Uehara T,Fukushima K. Year: 2005Progress of leukoaraiosis is inhibited by correction of platelet hyper-aggregability.Int Psychogeriatr1768969816271159|
Table 1 Patient characteristics (n = 50).
|Sex (male: female)||30∶20|
|Mean age (range)||67.7±9.9 (47–87) years|
|Patients with hypertension||42|
|Patients with diabetes mellitus||10|
|Mean total plaque volume (range)||943.3±286.0 (458.5–2000.6) mm3|
|Mean LRNC volume (range)||96.5±147.44 (0–557.2) mm3|
|Thick and intact||29|
|Thin and/or ruptured||21|
|Mean ipsilateral WML||6.52±8.17 (0.23–29.72) mm3|
|volume at baseline (range)|
|Mean ipsilateral WML||6.97±8.88 (0.17–32.02) mm3|
|volume after one year (range)|
Table 2 Results of Spearman rank correlation analyses for associations between clinical parameters, ipsilateral WML volume at baseline and ipsilateral WML volume progression after one year. Significant results are displayed in bold.
|Ipsilateral WML volume at baseline||Ipsilateral WML volume difference after one year|
|Spearman ρ||P-value||Spearman ρ||P-value|
|Ipsilateral WML volume at baseline||NA||NA||0.483||<0.001|
aHypertension was defined as a systolic blood pressure ≥140 mm Hg and/or a diastolic blood pressure ≥90 mm Hg, or treatment with antihypertensive medication.
bDiabetes mellitus was defined as reported use of medication for diabetes mellitus or fasting plasma glucose level ≥126 mg/dl.
cPatients were categorized into current, former and never smokers.
NA: not applicable
Previous Document: Partially randomized, non-blinded trial of DNA and MVA therapeutic vaccines based on hepatitis B vir...
Next Document: HP1-mediated formation of alternative lengthening of telomeres-associated PML bodies requires HIRA b...